Volume 3, Issue 3 (July 2024)
Health Science Monitor 2024, 3(3): 261-268 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nabilou B, Hamdollahzadeh A, Yusefzadeh H. The performance of a cardiovascular hospital in COVID-19 pandemic: a case study of a Middle East developing country. Health Science Monitor 2024; 3 (3) :261-268
URL: http://hsm.umsu.ac.ir/article-1-170-en.html
URL: http://hsm.umsu.ac.ir/article-1-170-en.html
Department of health economics and management, school of Public Health, Urmia University of Medical Sciences, Urmia, Iran
Abstract: (718 Views)
Background & Aims: The performance of hospitals has been affected by the COVID-19 pandemic. This study investigated the performance of a cardiovascular hospital using indicators such as admissions and revenue.
Materials & Methods: The medical records of patients with selected cardiovascular diseases were studied in a teaching cardiovascular hospital in the capital city of West Azerbaijan in the second quarter of 2019 and 2020. Data were collected from the medical records, including length of stay, hospitalization type, sex, age, insurance, deaths, and readmissions. Bills were collected from the revenue department and the hospital information system. Two performances, two results, and two control indicators were used. Revenue, length of stay, and bed occupancy rate were calculated for both periods. Data were analyzed using SPSS (version 16) and the Mann-Whitney statistical test.
Results: One thousand three hundred and forty-one cases were studied in two study periods, with 57% being hospitalized in 2019, showing a decline of 14% in 2020. A decrease was observed in the average length of stay and total revenue during the pandemic. The difference in the mean total revenue was significant for 2 years (P = 0.00). The percentage of readmissions decreased slightly, and deaths increased in 2020.
Conclusion: The COVID-19 pandemic undermined hospital performance. The analysis of the studied indicators showed that hospitalizations, bed occupancy rates, and total revenue followed a similar decreasing pattern in the selected hospital during the COVID-19 pandemic. The hospital should adopt appropriate strategies so that, in conditions identical to the COVID-19 pandemic, its performance is accompanied by the proper management of resources, efficiency, and minimal reduction in revenue.
Materials & Methods: The medical records of patients with selected cardiovascular diseases were studied in a teaching cardiovascular hospital in the capital city of West Azerbaijan in the second quarter of 2019 and 2020. Data were collected from the medical records, including length of stay, hospitalization type, sex, age, insurance, deaths, and readmissions. Bills were collected from the revenue department and the hospital information system. Two performances, two results, and two control indicators were used. Revenue, length of stay, and bed occupancy rate were calculated for both periods. Data were analyzed using SPSS (version 16) and the Mann-Whitney statistical test.
Results: One thousand three hundred and forty-one cases were studied in two study periods, with 57% being hospitalized in 2019, showing a decline of 14% in 2020. A decrease was observed in the average length of stay and total revenue during the pandemic. The difference in the mean total revenue was significant for 2 years (P = 0.00). The percentage of readmissions decreased slightly, and deaths increased in 2020.
Conclusion: The COVID-19 pandemic undermined hospital performance. The analysis of the studied indicators showed that hospitalizations, bed occupancy rates, and total revenue followed a similar decreasing pattern in the selected hospital during the COVID-19 pandemic. The hospital should adopt appropriate strategies so that, in conditions identical to the COVID-19 pandemic, its performance is accompanied by the proper management of resources, efficiency, and minimal reduction in revenue.
Type of Study: Research |
Subject:
Health Economics
Received: 2024/04/2 | Accepted: 2024/06/16 | Published: 2024/07/8
Received: 2024/04/2 | Accepted: 2024/06/16 | Published: 2024/07/8
References
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506. [DOI] [PMID]
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020;382(8):727-33. [DOI] [PMID] [PMCID]
3. Dashash M, Almasri B, Takaleh E, Abou Halawah A, Sahyouni A. Educational perspective for the identification of essential competencies required for approaching patients with COVID-19. Eastern Mediterranean Health Journal. 2020;26(9):1011-7. [DOI] [PMID]
4. De Filippo O, D'Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. New England Journal of Medicine. 2020;383(1):88-9. [DOI] [PMID] [PMCID]
5. Asdaghpour E, Baghaei R, Jalilifar N, Radmehr H, Shirzad M, Mirzaaghayan MR, et al. Iranian society of cardiac surgeons position statement for the treatment of patients in need of cardiac surgery in the COVID-19 pandemic period (Version I). Multidisciplinary Cardiovascular Annals. 2020;11(1). [DOI]
6. WHO. COVID-19 pandemic statistics. datadot [Internet]. [cited 2024 Jul 29]. COVID-19 cases | WHO COVID-19 dashboard. Available from: https://data.who.int/dashboards/covid19/cases 2023. [URL]
7. Normando PG, Araujo-Filho JdA, Fonseca GdA, Rodrigues REF, Oliveira VA, Hajjar LA, et al. Redução na Hospitalização e Aumento na Mortalidade por Doenças Cardiovasculares durante a Pandemia da COVID-19 no Brasil. Arquivos Brasileiros de Cardiologia. 2021;116:371-80. [DOI] [PMID] [PMCID]
8. Maselli-Schoueri JH, de Carvalho LEW, Rezende LF, Fonseca FLA, Ferrari G, Adami F. Hospital admissions associated with noncommunicable diseases during the COVID-19 outbreak in Brazil. JAMA Network Open. 2021;4(3):e210799-e. [DOI] [PMID] [PMCID]
9. Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. European heart journal. 2020;41(19):1852-3. [DOI] [PMID] [PMCID]
10. Cardiovascular Diseases Geneva, Switzerland: Wold HealthOrganization [Internet]; 2020. (accessed on 7 June 2023) Available Online: https://www.who.int/health-topics/cardiovascular-diseases. [URL]
11. Satiani B, Davis CA. The financial and employment effects of coronavirus disease 2019 on physicians in the United States. Journal of vascular surgery. 2020;72(6):1856-63. [DOI] [PMID] [PMCID]
12. Shah SA, Brophy S, Kennedy J, Fisher L, Walker A, Mackenna B, et al. Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people. EClinicalMedicine. 2022;49. [DOI] [PMID] [PMCID]
13. Chen Y, Cai M, Li Z, Lin X, Wang L. Impacts of the COVID-19 pandemic on public hospitals of different levels: six-month evidence from Shanghai, China. Risk Management and Healthcare Policy. 2021:3635-51. [DOI] [PMID] [PMCID]
14. Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. The Lancet. 2020;396(10248):381-9. [DOI] [PMID]
15. Khalid A, Ali S. COVID-19 and its Challenges for the Healthcare System in Pakistan. Asian bioethics review. 2020;12(4):551-64. [DOI] [PMID] [PMCID]
16. Ribeiro EG, Pinheiro PC, Nascimento BR, Cacique JPP, Teixeira RA, Nascimento JdS, et al. Impact of the COVID-19 pandemic on hospital admissions for cardiovascular diseases in a large Brazilian urban center. Revista da Sociedade Brasileira de Medicina Tropical. 2022;55:e0264-2021. [DOI] [PMID] [PMCID]
17. Behzadifar M, Aalipour A, Kehsvari M, Darvishi Teli B, Ghanbari MK, Gorji HA, et al. The effect of COVID-19 on public hospital revenues in Iran: An interrupted time-series analysis. Plos one. 2022;17(3):e0266343. [DOI] [PMID] [PMCID]
18. Kazempour-Dizaji M, Sheikhan F, Varahram M, Rouzbahani R, Vand MY, Khosravi B, et al. Changes in a hospital's costs and revenues before and after COVID-19: A case study of an Iranian hospital. Health Scope. 2021;10(3). [DOI]
19. Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Archives of Iranian medicine. 2019;22(4):204-10. [Google Scholar]
20. Saki N, Karandish M, Cheraghian B, Heybar H, Hashemi SJ, Azhdari M. Prevalence of cardiovascular diseases and associated factors among adults from southwest Iran: Baseline data from Hoveyzeh Cohort Study. BMC cardiovascular disorders. 2022;22(1):309. [DOI] [PMID] [PMCID]
21. Organization WH. Rapid assessment of service delivery for NCDs during the COVID-19 pandemic. Geneva: World Health Organization. 2020. [URL]
22. Zuin M, Mugnai G, Zamboni A, Zakja E, Valle R, Turiano G, et al. Decline of admission for acute coronary syndromes and acute cardiovascular conditions during COVID-19 pandemic in Veneto region. Viruses. 2022;14(9):1925. [DOI] [PMID] [PMCID]
23. Bhatt AS, Moscone A, McElrath EE, Varshney AS, Claggett BL, Bhatt DL, et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020;76(3):280-8. [DOI] [PMID] [PMCID]
24. Ahmed SAS, Ajisola M, Azeem K, Bakibinga P, Chen Y-F, Choudhury NN, et al. Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements. BMJ global health. 2020;5(8):e003042. [DOI] [PMID] [PMCID]
25. Maung KK, Marques-Vidal P. Impact of COVID-19 pandemic on cardiovascular diseases hospitalisation, management and mortality in Switzerland. Open Heart. 2023;10(1):e002259. [DOI] [PMID] [PMCID]
26. da Silva Etges APB, Cardoso RB, Marcolino MS, Ruschel KB, Coutinho AP, Pereira EC, et al. The economic impact of COVID-19 treatment at a hospital-level: investment and financial registers of Brazilian hospitals. Journal of health economics and outcomes research. 2021;8(1):36. [DOI] [PMID] [PMCID]
27. Etges APBdS, Grenon V, Lu M, Cardoso RB, de Souza JS, Kliemann Neto FJ, et al. Development of an enterprise risk inventory for healthcare. BMC health services research. 2018;18:1-16. [DOI] [PMID] [PMCID]
28. Langabeer JR, Lalani KH, Yusuf RA, Helton JR, Champagne-Langabeer T. Strategies of High-Performing teaching hospitals. Hospital topics. 2018;96(2):54-60. [DOI] [PMID]
29. Lalani K, Helton J, Vega FR, Cardenas-Turanzas M, Champagne-Langabeer T, Langabeer JR, editors. The impact of COVID-19 on the financial performance of largest teaching hospitals. Healthcare; 2023: MDPI. [DOI] [PMID] [PMCID]
30. Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L, et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. The Lancet. 2020;395(10238):1715-25. [DOI] [PMID]
31. Giattino C, Ritchie H, Roser M, Ortiz-Ospina E, Hasell J. Excess mortality during the Coronavirus pandemic (COVID-19). Our World Date. 2021. [URL]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
